PSC, Teil 1

Testen Sie Ihr Wissen mit unserem PSC-Quiz. Die Teilnahme ist freiwillig und eine Anmeldung ist nicht erforderlich.

 

Referenzen:

Björnsson E, Lindqvist‑Ottosson J, Asztely M, Olsson R. Dominant strictures in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2004;99(3):502‑508. PMID: 15056092.

Bowlus CL, Arrivé L, Bergquist A, et al. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology. 2023;77(2):659‑702. PMID: 36083140.

Cazzagon N, Sarcognato S, Floreani A, Corrà G, De Martin S, Guzzardo V, et al. Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis. JHEP Rep. 2021;3(3):100286. PMID: 34041468.

Chapman MH, Webster GJ, Bannoo S, Johnson GJ, Wittmann J, Pereira SP. Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25‑year single‑centre experience. Eur J Gastroenterol Hepatol. 2012;24(9):1051‑1058. PMID: 22653260.

Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M. Primary sclerosing cholangitis. Lancet. 2018;391(10139):2547‑2559. PMID: 29452711.

European Association for the Study of the Liver. EASL Clinical Practice Guidelines on sclerosing cholangitis. J Hepatol. 2022;77(3):761‑806. PMID: 35738507

Lazaridis KN, LaRusso NF. Primary sclerosing cholangitis. N Engl J Med. 2016;375(12):1161‑1170. PMID: 27653566.

Manns MP, Bergquist A, Karlsen TH, Levy C, Muir AJ, Ponsioen C, et al. Primary sclerosing cholangitis. Nat Rev Dis Primers. 2025;11(1):17. PMID: 40082445.

Mehta TI, Weissman S, Fung BM, Sotiriadis J, Lindor KD, Tabibian JH. Global incidence, prevalence and features of primary sclerosing cholangitis: a systematic review and meta‑analysis. Liver Int. 2021;41(10):2418‑2426. PMID: 34224208.

Visseren T, Erler NS, Heimbach JK, Eaton JE, Selzner N, et al. Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study. JHEP Rep. 2022 Oct 1;4(12):100599. PMID: 36426376